Chitta Lu News Today

Investegate announcements from Graft Polymer (UK), Director/PDMR Shareholding

  MGC Pharmaceuticals Ltd (ASX: MXC or "the Company")   advises the Companys Board and independent committees have, following the recent dual listing on the London Stock Exchange, and in conjunction with the Companys key advisors in the United Kingdom, agreed market appropriate changes to the remuneration and equity incentive structures of the Executive Directors and Key Management Personnel.  This includes a new performance rights program structured to retain the s...